Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lunghi

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Alimentary Pharmacology & Therapeutics|April 2, 2005
De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assayF Fabrizi, A F de Vecchi, G Como, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2005
Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantationF Fabrizi, P Lampertico, G Lunghi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 1996
IgM antibody response to hepatitis C virus in end-stage renal diseaseF Fabrizi, G Lunghi, I Guarnori, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 1996
Hepatitis C virus genotypes in chronic dialysis patientsF Fabrizi, G Lunghi, I Guarnori, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 31, 2001
Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitisF Fabrizi, G Lunghi, S Finazzi, et al.
The International Journal of Artificial Organs|January 24, 2004
Influence of hepatitis B virus virema upon serum aminotransferase activity in dialysis populationF Fabrizi, S Mangano, G Alongi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: a prospective studyF Fabrizi, G Lunghi, I Guarnori, et al.
Nephron|January 1, 1997
Molecular epidemiology of hepatitis C virus infection in dialysis patientsF Fabrizi, G Lunghi, B Pagliari, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 18, 2004
[HCV-related liver disease in hemodialysis population: clinical and biochemical characteristic]F Fabrizi, P Martin, G Lunghi, et al.
Transplantation Proceedings|September 2, 1998
Long-term evolution of anti-HCV-positive renal transplant recipientsA Aroldi, P Lampertico, A Elli, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Alimentary Pharmacology & Therapeutics|April 2, 2005
De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assayF Fabrizi, A F de Vecchi, G Como, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2005
Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantationF Fabrizi, P Lampertico, G Lunghi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 1996
IgM antibody response to hepatitis C virus in end-stage renal diseaseF Fabrizi, G Lunghi, I Guarnori, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 1996
Hepatitis C virus genotypes in chronic dialysis patientsF Fabrizi, G Lunghi, I Guarnori, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 31, 2001
Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitisF Fabrizi, G Lunghi, S Finazzi, et al.
The International Journal of Artificial Organs|January 24, 2004
Influence of hepatitis B virus virema upon serum aminotransferase activity in dialysis populationF Fabrizi, S Mangano, G Alongi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: a prospective studyF Fabrizi, G Lunghi, I Guarnori, et al.
Nephron|January 1, 1997
Molecular epidemiology of hepatitis C virus infection in dialysis patientsF Fabrizi, G Lunghi, B Pagliari, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 18, 2004
[HCV-related liver disease in hemodialysis population: clinical and biochemical characteristic]F Fabrizi, P Martin, G Lunghi, et al.
Transplantation Proceedings|September 2, 1998
Long-term evolution of anti-HCV-positive renal transplant recipientsA Aroldi, P Lampertico, A Elli, et al.
Pageof 8